Top Story

Patients with JIA undergoing total elbow arthroplasty had high complication, revision rates

October 29, 2014

Patients with juvenile idiopathic arthritis who undergo total elbow arthroplasty have high complication and revision rates but experience long-term benefits from intervention, according to study results.

Researchers identified 29 elbows in 24 patients that had been replaced due to juvenile idiopathic arthritis (JIA) between 1983 and 2005. The implant contour was modified for nine elbows and a customized implant was inserted in five elbows because of underlying deformity.

In the Journals

Patient costs greater at hospital-owned physician groups

October 28, 2014
Hospital-owned physician groups, often aggregated in order to provide coordinated care, had higher costs per patient than physician-owned organizations, according to…
In the Journals

Tofacitinib treatment led to small, reversible serum creatinine increases in RA patients

October 28, 2014
Patients with rheumatoid arthritis who underwent treatment with tofacitinib experienced small, reversible mean increases in serum creatinine that plateaued early…
Institution Notes

Institute of Medicine elects 70 new members

October 27, 2014
The Institute of Medicine elected 70 new members during its annual meeting on Oct. 20.Election to the IOM, considered one of the highest honors in the fields of health…
More News Headlines »
CME
figure

Rheumatoid Arthritis: Treatment Advances and Individualized Therapy

This activity is supported by an educational grant from Genentech

The management of rheumatoid arthritis is rapidly evolving, with the approvals of new medications, updates of…
More »
Meeting News Coverage Video
figure

Study: DSM-5 could not be properly applied to fibromyalgia patients

November 13, 2013
SAN DIEGO — Frederick Wolfe, MD, of the National Data Bank for Rheumatic Diseases, Wichita, Kan., presented…
More »
CME
figure

Fixed Versus Onflare Retreatment with Rituximab in RA Results from the Cererra Collaboration

This activity is co-sponsored by Albert Einstein College of Medicine of Yeshiva University and Vindico Medical Education

Cererra Collaboration is a collaboration between 12 European countries with the aim to describe the use of rituximab in…
More »